We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Test Detects Ovarian Cancer in Postmenopausal Women with Highest Accuracy Of 96%

By MedImaging International staff writers
Posted on 01 Oct 2024
Print article
Image: The ultrasound test outperformed the current standard of care in the UK significantly in the study (Photo courtesy of 123RF)
Image: The ultrasound test outperformed the current standard of care in the UK significantly in the study (Photo courtesy of 123RF)

Early diagnosis of ovarian cancer is crucial, as the earlier it is detected, the easier it is to treat, leading to more successful outcomes. A new study has now identified an ultrasound test that detected 96% of ovarian cancers in postmenopausal women, potentially offering a more effective alternative to the current standard of care in the UK.

In the high-quality diagnostic test accuracy study, researchers at the University of Birmingham (Birmingham, UK) compared all currently available tests to diagnose ovarian cancer in postmenopausal women head-to-head. Of the six tests evaluated, the IOTA ADNEX model, which examines ultrasound features (the appearance of the lump on the ultrasound), demonstrated the highest accuracy, detecting up to 96% of ovarian cancers. The findings, published in Lancet Oncology, revealed that this ultrasound test significantly outperformed the current standard of care used in the UK.

As a result, the researchers recommended replacing the existing Risk of Malignancy Index (RMI1) test—which detects 83% of ovarian cancers—with the IOTA ADNEX model. The study also highlighted that the model achieved its 96% accuracy when performed by NHS sonographers who received proper training and quality assurance. Since most ultrasounds globally are conducted by sonographers rather than gynecologists, the researchers have developed free online resources to help NHS staff complete the specialized training, obtain certification, and ensure quality assurance for the IOTA ADNEX model.

“This is the first time that a head-to-head study of all available ovarian cancer tests have been done in the same population. Here we studied their use with symptomatic, postmenopausal women who are most at risk of this cancer. Our trial found that the IOTA ADNEX ultrasound protocol had highest sensitivity for detecting ovarian cancer compared to the standard of care and other test,” said Sudha Sundar, Professor of Gynecological Cancer at the University of Birmingham and consultant in gynecological cancer surgery at Sandwell and West Birmingham NHS Trust. “The ultrasound test also performs well when delivered by a trained sonographer who have received specific training and certification and quality assurance, and as the vast majority of ultrasound scans are performed by sonographers it is important that a new standard is able to be delivered by as many clinical professionals as possible.”

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Opaque X-Ray Mobile Lead Barrier
2594M
New
Imaging Table
CFPM201
New
Mammography Analytics Platform
Unifi Analytics Software

Print article
Radcal

Channels

MRI

view channel
Image: MRI-linac allows clinicians to see what’s going on in the brain for the first time (Photo courtesy of Sylvester Comprehensive Cancer Center)

MRI Provides Early Warning System for Glioblastoma Growth

A new study has demonstrated the potential of combining imaging with radiation to shape glioblastoma treatment in real time. The research is the first to quantify tumor changes in glioblastoma patients... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

General/Advanced Imaging

view channel
Image: A kidney showing positive [89Zr]Zr-girentuximab PET and histologically confirmed clear-cell renal cell carcinoma (Photo courtesy of Dr. Brian Shuch/UCLA Health)

Non-Invasive Imaging Technique Accurately Detects Aggressive Kidney Cancer

Kidney cancers, known as renal cell carcinomas, account for 90% of solid kidney tumors, with over 81,000 new cases diagnosed annually in the United States. Among the various types, clear-cell renal cell... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Focused ultrasound therapy is poised to become an essential tool in every hospital, cancer care center and physician office (Photo courtesy of Arrayus)

Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer

Pancreatic cancer remains one of the most difficult cancers to treat due to its dense tissue structure, which limits the effectiveness of traditional drug therapies. Bracco Imaging S.A. (Milan, Italy)... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.